Pneumococcal Vaccination among Adults with Respiratory Diseases-Indications, Adherence and Roadblocks

Pneumococcal Vaccination among Adults with Respiratory Diseases-Indications, Adherence and Roadblocks

Introduction: Globally, invasive pneumococcal disease poses a major challenge to the health system and causes significant economic burden. Pneumococcal vaccination is a recommended and well adhered practice among paediatric age groups as opposed to adult population, where it is often overlooked or i...

Full description

Bibliographic Details
Main Authors:	Divya Ramachandran, Rajesh Venkitakrishnan, Jolsana Augustine, Melcy Cletus
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2018-11-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	adult vaccines chronic lung diseases pneumococcal infections
Online Access:	https://jcdr.net/articles/PDF/12301/37672_CE[Ra1]_F(SL)_PF1(AGAK)_PFA(AK)_PB(PAG)_PN(P).pdf

Similar Items

Vaccination against pneumococcal infections in adults
by: Kozlov R.S., et al.
Published: (2018-02-01)

VACCINE PREVENTION OF PNEUMOCOCCAL INFECTIONS IN ADULTS
by: A. A. Zaitsev, et al.
Published: (2017-11-01)

Pneumococcal and Influenza Vaccination Coverage Rates of Adult Patients at Risk and Their Attitudes Towards Vaccination
by: Lale ÖZIŞIK, et al.
Published: (2016-03-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Pneumococcal vaccination and chronic respiratory diseases
by: Froes F, et al.
Published: (2017-12-01)

Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals
by: Yousef A Almusalam, et al.
Published: (2019-01-01)

Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
by: Starla Hayward, et al.
Published: (2016-04-01)

Vaccination against pneumococcal infection in adults from risk groups
by: N. I. Briko, et al.
Published: (2020-06-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
by: Hiroaki Takeda, et al.
Published: (2019-01-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Seasonal influenza and pneumococcal vaccination in institutionalized older adults
by: Chan, Tuen-ching, et al.
Published: (2015)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
by: Nicola Principi, et al.
Published: (2016-12-01)

Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
by: Gerwin D. Rodenburg, et al.
Published: (2010-05-01)

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
by: Stephanie Perniciaro, et al.
Published: (2021-08-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review
by: Fan, Hiu-yan, et al.
Published: (2014)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
by: Giske Biesbroek, et al.
Published: (2014-02-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Invasive pneumococcal disease in the post vaccine era: Case report
by: Edwin Albino H, et al.
Published: (2016-03-01)

Invasive pneumococcal disease in the post vaccine era: Case report
by: Edwin Albino H. Miranda Choque, et al.
Published: (2016-01-01)

Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care Providers
by: Patricia Sacco, et al.
Published: (2019-09-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
by: Deborah Lehmann, et al.
Published: (2017-12-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review
by: Wong, Kwan-ting, et al.
Published: (2014)

Uptake of pneumococcal vaccination in older people in northern Israel
by: Sophia Eilat-Tsanani, et al.
Published: (2021-12-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
by: Choon How How, et al.
Published: (2016-09-01)

The remaining challenges of pneumococcal disease in adults
by: E. Ludwig, et al.
Published: (2012-03-01)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
by: Earnshaw Stephanie R, et al.
Published: (2012-04-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?
by: Alice Laurence, et al.
Published: (2016-06-01)

Cannot write session to /tmp/vufind_sessions/sess_b3qnbuhk5u1otikdkc5qi3ebr8